Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-07-000901
Filing Date
2007-03-01
Accepted
2007-03-01 17:05:59
Documents
9
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FOM 10-K w30629e10vk.htm 10-K 1588363
2 EX-12 w30629exv12.htm EX-12 24178
3 EX-21 w30629exv21.htm EX-21 4242
4 EX-23 w30629exv23.htm EX-23 2465
5 EX-31.1 w30629exv31w1.htm EX-31.1 5694
6 EX-31.2 w30629exv31w2.htm EX-31.2 5702
7 EX-32.1 w30629exv32w1.htm EX-32.1 3164
8 EX-32.2 w30629exv32w2.htm EX-32.2 3179
9 GRAPHIC w30629w3062901.gif GRAPHIC 5863
  Complete submission text file 0000950133-07-000901.txt   1646758
Mailing Address 5775 WEST OLD SHAKOPEE RD SUITE 100 MINNEAPOLIS MN 55437
Business Address 5775 WEST OLD SHAKOPEE RD SUITE 100 BLOOMINGTON MN 55437 952-346-4700
MGI PHARMA INC (Filer) CIK: 0000702131 (see all company filings)

EIN.: 411364647 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-10736 | Film No.: 07664459
SIC: 2834 Pharmaceutical Preparations